Rheumatoid Arthritis Recruiting Phase 4 Trials for Tocilizumab (DB06273)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03737708A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)Treatment
NCT03227419Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate RespondersTreatment
NCT02087696Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid ArthritisTreatment
NCT03100253Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGationTreatment
NCT02765074Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid ArthritisTreatment
NCT03781310Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid ArthritisTreatment
NCT02466581Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease ActivityTreatment